COMPARISON OF SECUKINUMAB VERSUS ADALIMUMAB EFFICACY ON SKIN OUTCOMES IN PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM THE EXCEED STUDY

被引：0

作者：

Gottlieb, A. B. ^{[1
]}

Behrens, F. ^{[2
,3
]}

Nash, P. ^{[4
]}

Merola, J. F. ^{[5
]}

Ding, K. ^{[6
]}

Pellet, P. ^{[7
]}

Pricop, L. ^{[6
]}

Mcinnes, I. ^{[8
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Rheumatol Univ Hosp, Frankfurt, Germany

[3] Goethe Univ, Frankfurt, Germany

[4] Griffith Univ, Brisbane, Qld, Australia

[5] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[6] Novartis Pharmaceut, E Hanover, NJ USA

[7] Novartis Pharma AG, Basel, Switzerland

[8] Univ Glasgow, Glasgow, Lanark, Scotland

来源：

关键词：

D O I：

10.1136/annrheumdis-2020-eular.4736

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0340

引用

页码：759 / 760

页数：2

共 2 条

[1] Psoriatic arthritis: state of the art review
Coates, Laura C.
Helliwell, Philip S.
[J]. CLINICAL MEDICINE, 2017, 17 (01) : 65 - 70
[2] Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Langley, Richard G.
Elewski, Boni E.
Lebwohl, Mark
Reich, Kristian
Griffiths, Christopher E. M.
Papp, Kim
Puig, Lluis
Nakagawa, Hidemi
Spelman, Lynda
Sigurgeirsson, Bardur
Rivas, Enrique
Tsai, Tsen-Fang
Wasel, Norman
Tyring, Stephen
Salko, Thomas
Hampele, Isabelle
Notter, Marianne
Karpov, Alexander
Helou, Silvia
Papavassilis, Charis
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (04) : 326 - 338